. The T6SS is comprised of a cell envelope-spanning membrane complex and a cytoplasmic assembly that shares structural similarity to the baseplate, sheath, tube and spike components of contractile bacteriophages 5, 6 . The tube component of this assembly is formed by stacks of the hexameric protein Hcp, which is enclosed by a sheath complex that, following T6SS activation, is believed to mechanically contract and propel the inner tube outwards from the bacterial cell 7, 8 . An arrowhead-like tip on the Hcp nanotube is formed by a complex between a trimeric protein called VgrG and a proline-alanine-alanine-arginine (PAAR) domain-containing protein. This spike complex probably mediates the first point of contact of the T6SS with the recipient cell 9 . There is compelling genetic and biochemical evidence indicating that effectors are delivered to the periplasm, where a subset then translocates to the cytoplasm 4 . Intoxication of effector-producing cells and adjacent sister cells does not occur because each effector is co-expressed with a cognate immunity protein that neutralizes the activity of its associated effector through a direct binding mechanism 10 . Owing to their differing sizes, effectors have been shown to transit the T6SS via two mechanisms 11 . Smaller effectors (< 40 kDa) bind the lumen of Hcp hexamers and are stabilized by this interaction, whereas large, multi-domain effectors bind VgrG [12] [13] [14] . In recent work, genes encoding chaperone proteins have been shown to be required for the association of a subset of effectors with VgrG, with three chaperone domain superfamilies implicated in this process 15, 16 . One of these families, designated DUF1795, includes EagT6 of Pseudomonas aeruginosa and EagR1 of Serratia marcescens. The precise function of this chaperone family is not known; however, EagT6 and EagR1 are required for the intracellular stability of the PAAR domain-containing effectors Tse6 (also known as Tne1) and RhsA, respectively [17] [18] [19] . Furthermore, both Eag proteins have been shown to directly bind the N-terminal region of their cognate effectors 18, 19 . Tse6 is unique in that it also requires interaction with the elongation factor Tu (EF-Tu) for its delivery into recipient bacteria, although the precise role this housekeeping protein plays in the intoxication process is not known 19 . Molecular insights into the various T6SS apparatus subcomplexes, including the membrane complex 20 and the sheath complex in extended and contracted states 21, 22 , have been obtained by single particle electron cryomicroscopy (cryo-EM) studies. In addition, X-ray crystal structures of numerous effector proteins 23 , as well as secreted structural components such as VgrG, have been determined 24 . However, structures of VgrG in complex with effectorchaperone complexes, which are needed to understand chaperone function, have yet to be determined.
Here, we present the cryo-EM structure of the T6SS effectorchaperone pair Tse6-EagT6 in complex with VgrG1. The structure reveals that two homodimers of the EagT6 chaperone shield the hydrophobic transmembrane domains (TMDs) of the effector Tse6.
In biochemical experiments, we show that both interactions are crucial for the specific loading of Tse6 onto VgrG1 and intoxication of target cells. Furthermore, by reconstituting the Tse6-loaded VgrG1 complex into liposomes and nanodiscs we show that Tse6 is able to spontaneously enter membranes and translocate its toxin domain across a lipid bilayer.
Results
Architecture of a pre-firing effector complex. We previously demonstrated that Tse6 is a T6SS-exported effector protein that requires EagT6 for intercellular toxicity 19 . Furthermore, we determined a low-resolution negative stain EM structure of a complex containing VgrG1-Tse6-EagT6-EF-Tu and the Tse6-specific immunity protein Tsi6, which provided initial insights into how these proteins interact 19 . However, the resolution of this structure limited our understanding of the role that EagT6 plays within this assembly.
To better understand EagT6 function, we analysed the structure of the 'pre-firing' VgrG1-Tse6-EagT6-EF-Tu-Tsi6 complex (PFC) by cryo-EM and single-particle analysis 25 . The overall resolution of the reconstruction was 4.2 Å and, as described below, comprises VgrG1, the N-terminal PAAR and TMDs of Tse6 (hereafter referred to as Tse6 PAAR and Tse6 TMDs , respectively), and two homodimers of EagT6 (Fig. 1a, Supplementary Figs 1a-d , 2-4 and Supplementary Table 1 ). The C-terminal toxin domain of Tse6 (Tse6 tox ), EF-Tu and Tsi6 could not be resolved, indicating that this subcomplex is highly flexible. The clear separation of the β -sheets in the C-terminal triple-stranded β -helix of VgrG1 allowed us to build a refined model of VgrG1 using the deposited crystal structure (pdb:4MTK) as a template (Supplementary Table 1 ). We assigned the cone-shaped density below VgrG1 to the tapering Tse6 PAAR (yellow triangle in Fig. 1a ) that is known to bind to VgrG1 9 . Since the resolution in this region is not sufficient to build an atomic model de novo, we calculated a homology model of Tse6 PAAR and fitted it into the density using rigid-body fitting 26 . Flanking Tse6 PAAR at the bottom are two striking horseshoe-shaped densities, the form of which clearly identifies them as two EagT6 dimers. The previously obtained atomic model of EagT6 (pdb:1TU1) fits optimally into these densities. The EagT6 dimers are located directly opposite each other, with the concave openings facing towards the centre. Interestingly, one of the EagT6 dimers is rotated by ~50˚, resulting in different interfaces with Tse6 PAAR (Fig. 1e) .
Many nonpolar residues are located on the concave surface of EagT6, creating a hydrophobic cavity suited to accommodate the two predicted TMD regions of Tse6 (TMD-1 and TMD-2). The exact number of transmembrane helices in each of the TMDs is not known; however, membrane topology servers consistently predict two transmembrane helices for TMD-1, whereas the predictions for TMD-2 vary from one to three ( Supplementary Fig. 5 ). Consistent with a direct interaction between the TMDs of Tse6 with EagT6, we observed additional density in the concave cavity of both EagT6 dimers (Fig. 1a-c) . For one of the EagT6 dimers, a distinct tubular density suggests the binding of a transmembrane helix (Fig. 1b) . The density enclosed by the second EagT6 dimer is less well defined, suggesting either a higher degree of flexibility or more than one transmembrane helix (Fig. 1c) .
To test the proposed interactio n between the TMDs of Tse6 and EagT6, we created TMD-deletion mutants in which each individual TMD region (Tse6 ΔTMD-1 , Tse6 ΔTMD-2 ) or both TMD regions (Tse6 ΔTMD-1,ΔTMD-2 ) was deleted and performed pull-down assays with EagT6 (Fig. 2a,b) . In these experiments, Tse6 co-purified with EagT6 when either of the individual TMD regions were removed but not when both were absent (Fig. 2b) . Together with our cryo-EM structure, these data demonstrate that each TMD probably interacts with a homodimer of EagT6. We next examined the consequences of removing the TMDs of Tse6 in vivo. Previously, we showed that wild-type Tse6 requires interaction with EagT6 for stability in vivo, perhaps because exposed hydrophobic TMDs result in an unstable protein 19 . However, in contrast to wild-type Tse6, we found that Tse6 ΔTMD-1,ΔTMD-2 is highly stable in the absence of EagT6 (Supplementary Fig. 6a ). To rule out the possibility that deleting the TMDs of Tse6 results in aggregation of misfolded protein, we next assessed the ability of Tse6 ΔTMD-1,ΔTMD-2 to inhibit bacterial growth. We found that full-length Tse6 requires co-expression with EagT6 to inhibit the growth of Escherichia coli, presumably due to the stability imparted to Tse6 by EagT6. In contrast, Tse6 ΔTMD-1,ΔTMD-2 is highly toxic in the absence of EagT6 (Fig. 2c) . Self-intoxication assays in P. aeruginosa with isopropyl-β -D-1-thiogalactopyranoside (IPTG)-induced depletion of Tsi6 produced similar results (Fig. 2d) . These data indicate that the TMDs of Tse6 impart instability on the protein, which is prevented through the interaction with EagT6.
The structure of the EagT6 homodimer suggests that a concave cavity and its hydrophobic nature probably mediate its interaction with the TMD regions of Tse6. To test this, we introduced mutations at the eagT6 locus of P. aeruginosa that encode site-specific variants of the EagT6 protein and examined whether mutated EagT6 is still able to stabilize Tse6 in vivo (Fig. 1d) . Indeed, substitutions of hydrophobic residues in the concave cavity reduced Tse6 stability, whereas mutations in other regions of the EagT6 dimer had no effect (Fig. 1d) . For further validation, we tested the ability of each individual TMD fragment of Tse6 to pull down EagT6 ( Supplementary  Fig. 7 ). In these experiments, both the TMD-1 and the TMD-2 fragments of Tse6 pulled down EagT6. Furthermore, one of our hydrophobic substitution mutants (V39Q) located within the EagT6 concave cavity, substantially reduced these interactions. Thus, we conclude that one EagT6 dimer interacts with each of the TMD regions of Tse6 and that these interactions occur via the concave surface of EagT6.
Two-dimensional (2D) class averages of the PFC indicated that part of the complex is highly flexible, only appearing as diffuse density at its lower part (Fig. 3a, Supplementary Video 1) . This density is not resolved in the three-dimensional (3D) reconstruction but based on our previous characterization of Tse6 interaction partners, it corresponds to the Tse6 tox -EF-Tu-Tsi6 subcomplex 19 . A long linker connects the last resolved domain Tse6 TMD-2 with the first unresolved domain Tse6 tox . The linker probably acts as a hinge that allows large movements, explaining the flexibility of the Tse6 tox -EF-Tu-Tsi6 subcomplex. The broad range of localization of the subcomplex respective to the core complex becomes more apparent when calculating a 3D variability map (Fig. 3b,c) .
Interaction with EagT6 is required for Tse6 loading onto VgrG1.
We next sought to determine whether EagT6-TMD interactions play any additional roles in Tse6 export beyond conferring stability to the effector. The close proximity of the EagT6 homodimers to Tse6 PAAR led us to hypothesize that they might also facilitate the loading of the effector onto VgrG1. To test this, we performed immunoprecipitation assays on E. coli cells co-expressing Tse6 and either of its TMD-deletion mutants with EagT6 and VgrG1. In these experiments, wild-type Tse6 formed a complex with VgrG1 that was resistant to both SDS and heat denaturation. However, deletion of either of the TMDs abrogated the formation of this highly stable complex (Fig. 4a ). Mirroring our in vitro results, we found that when expressed from the native tse6 locus in P. aeruginosa, Tse6 variants lacking either TMD region were unable to form SDS-resistant complexes with VgrG1 (Fig. 4b) . Mutational inactivation of vgrG1 (but not the related vgrG4 gene) abrogated complex formation, indicating that the interaction with VgrG1 is specific. From these data, we conclude that the EagT6 interaction is essential for the formation of a highly stable Tse6-VgrG1 complex.
Tse6 is exported by the P. aeruginosa H1-T6SS. In addition to Tse6, this pathway is known to secrete a second PAAR domain-containing effector termed Tse5
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. Consistent with the recent demonstration that at least one PAAR domain is required for a functional T6SS 18 , we found that when the genes encoding these two H1-T6SS-delivered PAARcontaining proteins of P. aeruginosa were inactivated, cells were no longer able to secrete the H1-T6SS effector Tse1 ( Supplementary  Fig. 6b) . The same effect was demonstrated when tse5 was deleted in a strain expressing Tse6 ΔTMD-1,ΔTMD-2 ( Supplementary Fig. 6b ). This result further highlights the necessity of the TMDs of Tse6 for PAARmediated VgrG1-Tse6 complex formation.
To determine whether the SDS-resistant Tse6-VgrG1 complex is necessary for the intoxication of Tse6-susceptible bacteria, we subjected the TMD-deletion mutants to bacterial competition assays (Fig. 4c ). The parental strain had the anticipated fitness advantage over a Tse6-susceptible strain; however, strains expressing Tse6 that lacks any of its transmembrane regions were unable to outcompete this recipient, implying that the highly stable Tse6-VgrG1 complex is essential for the intoxication of target cells.
Having established a role for EagT6 in loading Tse6 onto VgrG1, we next wanted to determine whether EagT6 is also involved in effector delivery into recipient bacteria. To test this, we performed secretion assays using P. aeruginosa and found that, in contrast to Tse6, EagT6 is not secreted and thus is retained in the bacterium ( Supplementary Fig. 6c ). These findings are consistent with data from another recently characterized member of the Eag chaperone family from S. marcescens 18 . Thus, EagT6 stabilizes both TMDs , fit of available atomic structures into cryo-EM density map (middle) and colour-coded segmented cryo-EM density map (right) of the VgrG1-Tse6-EagT6 2 -EF-Tu-Tsi6 complex. Tse6 tox , EF-Tu and Tsi6 are not well resolved due to flexibility (see also Fig. 3 ). The density corresponding to VgrG1 is shown at a higher threshold for improved visualization. The exact number of transmembrane helices in each TMD is not known. Predictions give a range of one to three helices (see also Supplementary Fig. 5 ). The two most likely arrangements for TMD-2 have either one or three transmembrane helices. b,c, Side views of the cavity of the two opposing EagT6 dimers are shown with an atomic model fitted into the density (left) and a corresponding schematic representation (right). The additional densities (orange) inside the cavity have a tubular appearance and probably correspond to the transmembrane helices of TMD-1 and TMD-2 of Tse6. In one of the cavities, the enclosed density is less defined, indicating a higher degree of flexibility and/or more than one transmembrane helix (c). For corresponding top views, see Supplementary Fig. 1d . d, Single point mutations at the surface of EagT6 identifying residues that interact with Tse6. The upper panel shows a western blot analysis of Tse6 and EagT6 levels in the indicated P. aeruginosa strain. Different point mutations were introduced in chromosomally VSV-G (V)-tagged EagT6. The lower panel shows the effect of mutated residues mapped on the surface of EagT6: those interacting with Tse6 are shown in orange and those with no effect are shown in blue. e, Close-up view of the interfaces between the two EagT6 dimers and Tse6 PAAR . See also Supplementary Figures 1-5 and Supplementary Tables 1-3. of Tse6, which are necessary for the loading of Tse6 onto VgrG1; however, it is not co-secreted with the Tse6-loaded VgrG1 complex. It is therefore crucial for effector loading but not delivery into target bacteria.
Tse6 tox is translocated across membranes. The toxin domain of Tse6 acts in the cytoplasm of recipient bacteria, where it hydrolyzes the essential dinucleotides nicotinamide adenine dinucleotide (NAD + ) and nicotinamide adenine dinucleotide phosphate (NADP + ). However, the molecular details of how this domain breaches the inner membrane to reach this cellular compartment are not known 19 . The presence of two TMD regions within Tse6 suggests that it may be capable of entering membranes and self-translocating its enzymatic domain. To test this hypothesis, we devised a liposome-based assay in which we incubated NAD + -loaded liposomes with the VgrG1-Tse6-EF-Tu-Tsi6 complex (hereafter referred to as Tse6-loaded VgrG1 complex) and measured the levels of NAD + inside the liposomes (Fig. 4d ,e). In comparison to control liposomes, a significant decrease in NAD + concentration was observed in the presence of the Tse6-loaded VgrG1 complex, indicating the successful translocation of the Tse6 tox domain into the interior of the liposomes (Fig. 4e) . To ensure that the needle-shaped particles themselves do not puncture liposomes and cause leakage of NAD + , we also tested complexes containing a catalytically inactive variant of Tse6 (Tse6 Q333D,D396A ) or with Tse6 lacking its C-terminal toxin domain (Tse6 Δtox ). We observed no significant decrease in NAD + levels when incubating the mutant complexes with liposomes, indicating that the integrity of liposomes is not compromised (Fig. 4e , Supplementary Fig. 8a ). Negative stain EM of the liposomes clearly showed that the Tse6-loaded VgrG1 complexes decorated the liposomes with Tse6 entering the membrane (Fig. 4d ). Nanogold labelling of the His 8 -tagged Tse6 tox further corroborated its successful translocation over the membrane ( Supplementary  Fig. 8b ). However, the complex containing Tse6 Δtox did not readily enter liposomes, indicating that the complete Tse6 protein is needed for membrane penetration ( Supplementary Fig. 8c ). These results demonstrate that Tse6 enters the membrane without the need of an additional receptor and translocates its toxin domain across the bilayer.
To obtain a high-resolution structure of this complex embedded in a lipid bilayer, we next exploited the self-insertion capability of the Tse6-loaded VgrG1 complex and reconstituted it in preformed nanodiscs, mimicking the membrane insertion process in situ. We validated the successful insertion of the complex into nanodiscs by negative stain electron microscopy ( Supplementary Fig. 9 ). Either one or two of the complexes were embedded in one nanodisc. The two fractions could be separated by size-exclusion chromatography ( Supplementary Fig. 9a ) and the peak containing one complex per nanodisc was used for cryo-EM ( Supplementary Fig. 1e-i ).
In agreement with our liposome assay, nanogold labelling of the His 8 -tagged Tse6 tox domain demonstrates that this domain is located on the other side of the bilayer indicating that Tse6 tox translocated through the membrane (Fig. 5a,c) . Furthermore, we observed that following reconstitution into membranes, Tsi6 was no longer associated with the Tse6-loaded VgrG1 complex after size exclusion chromatography, indicating that it dissociated from the complex on its insertion into the membrane (Fig. 5a ). Wild type
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T s e 6 Using cryo-EM and single-particle analysis we determined the structure of the VgrG1-Tse6-EF-Tu complex embedded in lipid nanodiscs (Fig. 5b ,c, Supplementary Figs 1e-i,2 and 3). In this structure, the density of VgrG1 and the nanodisc is clearly recognizable, whereas additional density corresponding to Tse6 tox and EF-Tu is also apparent (Fig. 5c ). Although 2D class averages clearly show the outlines of the nanodisc, as well as secondary structure elements in VgrG1 (Fig. 5a, Supplementary Figs 1e and 2c) , the resolution of this reconstruction was limited to ~11 Å ( Supplementary Fig. 1g ). Attempts to increase the resolution were impeded due to several difficulties. First, the regions of Tse6 connecting its PAAR domain to its TMDs induce substantial flexibility, which allows the TMDs embedded in the nanodisc to wobble (Fig. 5b,d and Supplementary  Fig. 1h ). Second, lateral movements of the TMDs inside the nanodisc, as well as the dynamic nature of the Tse6 tox -EF-Tu subcomplex ( Fig. 5b and Supplementary Fig. 1h,i) further aggravated image processing.
Nevertheless, we were able to resolve the region of our complex containing VgrG1 to a final resolution of 3.2 Å by imposing C 3 symmetry ( Fig. 5e and Supplementary Video 2) . The resulting atomic model was almost identical to that of VgrG1 before membrane insertion (Supplementary Table 1 24 . In the closed conformation, there is a large loop that protrudes into the bowl-shaped cavity of VgrG1, restricting its diameter. In this conformation, several C-terminal residues adopt a fold that is not favourable for PAAR interaction. When comparing our cryo-EM structure of VgrG1 before and after membrane insertion, it becomes evident that both structures are in the open conformation (Fig. 5f ). The obtained density map correlated even on the side-chain level with the crystal structure of VgrG1 in the open conformation ( Fig. 5f and Supplementary Table 1) . We therefore propose that the open conformation is the physiological relevant form of VgrG1.
Conserved N-terminal loading and translocation region in
Proteobacteria. The PAAR domain and its flanking TMDs are comprised of the roughly 250 N-terminal amino acids of Tse6 ( Supplementary Fig. 10a ). Having established that the entirety of this region is required for Tse6 loading onto VgrG1, we next wanted to examine the conservation of this domain arrangement within Proteobacteria (Supplementary Figs 10a and 11) . Interestingly, we found this N-terminal domain arrangement to be present in many predicted T6SS effectors from diverse Gram-negative bacteria ( Supplementary Fig. 10a) . Furthermore, the majority of these TMDcontaining effectors also have predicted chaperone genes in their immediate genetic neighbourhood ( Supplementary Fig. 10b ). Based on our findings presented here, we designate the conserved region of these effectors the 'N-terminal loading and translocation region' (NLTR). In line with previously published informatic studies 27 , we found the C terminus of NLTR-containing proteins to be highly sequence divergent and these are predicted to encode toxins with a variety of enzymatic activities ( Supplementary Fig. 10a ). Given the conservation of the NLTR among Proteobacteria ( Supplementary  Fig. 11 ), we believe that the mechanism of effector loading and translocation, mediated through the NLTR, is paradigmatic for all Eag-associated effectors. Our observations support a generalizable function of Eag proteins in the stabilization and loading of effectors onto their cognate VgrG proteins (Fig. 6 ). 
Discussion
With our cryo-EM reconstruction of the PFC core, comprising VgrG1, Tse6 PAAR , Tse6 TMDs and EagT6 2 , we characterized the structure of a T6SS effector-chaperone pair loaded onto its cognate VgrG. Together with our biochemical data, we also uncover the role of EagT6 in Tse6-mediated interbacterial killing. We show that the hydrophobic TMDs of Tse6 are shielded from the hydrophilic environment of the cytoplasm by EagT6 to prevent aggregation and degradation of Tse6. Furthermore, we demonstrate that the association of EagT6 with the TMDs of Tse6 allows its PAAR domain to interact with VgrG1, which is then loaded into the T6SS apparatus.
The necessity of EagT6 for Tse6 recruitment to the T6SS shares some similarities with membrane protein export by the host-cell targeting bacterial type III secretion system (T3SS). The T3SS translocon is a pore formed at the tip of the T3SS apparatus that allows soluble effectors to access the host cell cytoplasm. The membrane protein that forms the translocon is itself a T3SS substrate and requires a cognate chaperone for solubility in the bacterial cytoplasm before its loading into the T3SS apparatus. Structural studies of the AcrH T3SS chaperone from Aeromonas hydrophila show that, like EagT6, it directly binds and stabilizes the transmembrane domains of the AopB translocon before its export from the cell 28 . We have also shown that Tse6 is capable of entering membranes and that its toxin domain is able to self-translocate across a lipid bilayer. Based on these observations, we propose that the T6SS delivers the Tse6-VgrG1 complex into the periplasm and spontaneous membrane insertion allows Tse6 tox to translocate across the inner membrane into the cytoplasm, where it exerts toxicity. Membrane translocation has recently been shown for the VgrG3 and TseL effectors of Vibrio cholerae 29 . Both effectors target periplasmic substrates. Interestingly, they exerted their toxic activity in the periplasm even though they were produced in the cytosol. The authors suggest that the effectors are translocated across the inner membrane by an intrinsic membranepenetrating activity or by an as-yet-unknown active transport mechanism. TseL and VgrG3 are not predicted to contain TMDs; their mechanism of membrane translocation is therefore likely to differ from that of Tse6.
The role of EF-Tu binding in the interbacterial delivery of Tse6 is still not understood. We previously proposed that EF-Tu present in the recipient cell might act as a molecular ratchet by preventing the toxin domain of Tse6 from translocating back into the periplasm once it enters the cytoplasm 19 . In our in vitro translocation assay, EF-Tu is only present on the outside but not on the inside of NAD + -loaded liposomes. Therefore, we can exclude that EF-Tu on the other side of the membrane is required for the translocation of the toxin domain of Tse6 across a lipid bilayer. Whether EF-Tu functions to anchor the toxin domain of Tse6 within the cytoplasm after its translocation across the inner membrane remains to be determined and will be the subject of future study.
The ability of Tse6 to translocate its toxin domain across membranes without the help of accessory factors is remarkable and poses the question of how this task is accomplished. The TMDs of Tse6 are predicted to possess up to five total transmembrane helices, which are probably unable to form a pore large enough to accommodate the 17 kDa toxin domain in its folded state. We therefore suggest a scenario in which the TMDs of Tse6 form a small translocation pore that allows unfolded Tse6 tox to thread through and ultimately refold in the cytosol of the target cell. This unfolding might be induced by the interaction of the transmembrane helices with the inner membrane and translocation could be catalysed by refolding in the cytoplasm. In line with this, we have shown that the toxin domain of Tse6 readily refolds in vitro 19 . This model shares similarity with the current model for membrane translocation by the Corynebacterium diphtheriae diphtheria toxin. This toxin is capable of translocating its enzymatic A fragment through a pore created by two membraneinserted α -helical hairpins belonging to the translocation domain of the B fragment 30 . This study provides detailed insight into both the mechanism of effector loading onto VgrG proteins and the delivery of the Tse6 toxin across the membrane of the target cell. It not only enhances our knowledge about how the T6SS machinery functions, but also lays the foundation for a mechanistic understanding of the vital role of T6SS in interbacterial killing within bacterial communities. Ultimately, these insights could lead to the development of novel treatments for drug-resistant pathogens.
Methods
Bacterial strains, plasmids and growth conditions. All generated P. aeruginosa strains were derived from the sequenced strain PAO1 (Supplementary  Table 2) 31 . P. aeruginosa was grown in Luria-Bertani (LB) media at 37 or 30 °C supplemented with 30 μ g ml −1 gentamicin, 25 μ g ml −1 irgasan, 40 μ g ml
5-bromo-4-chloro-3-indolyl-β -D-galactopyranoside (X-gal), 5% (w/v) sucrose and 0.5 mM IPTG as required. In-frame deletions, chromosomal fusions and chromosomal point mutations were generated as previously described using the pEXG2 suicide vector 1, 32 . The plasmid pPSV38 was used for inducible protein expression in P. aeruginosa. E. coli strains required for this study included XL1-Blue for plasmid maintenance, SM10 for conjugal transfer of allelic exchange plasmids into P. aeruginosa and BL21 Codon Plus (Novagen) for protein overexpression and toxicity experiments. E. coli strains were grown at 37 °C in media supplemented with 50 μ g ml −1 kanamycin, 150 μ g ml −1 carbenicillin, 30 μ g ml −1 chloramphenicol, 200 μ g ml −1 trimethoprim, 0.1% (w/v) L-rhamnose and the indicated concentrations of IPTG as required. The plasmids used for inducible protein expression in E. coli were pETDuet-1, pSCrhaB2-CV, pPSV35-CV and pRSFDuet-1.
Protein expression and purification. Expression of the VgrG1-Tse6-EagT6 2 -EF-Tu-Tsi6 complex was performed as described previously 19 . Briefly, 12 l E. coli BL21 CodonPlus cells harbouring pETDuet-1::tse6-his 8 ::tsi6 and pRSFDuet-1::vgrG1::eagT6 were grown at 37 °C to mid-log phase and protein expression was induced by the addition of 1 mM IPTG. Following incubation at 30 °C for an additional 5-6 h, cells were pelleted and lysed in either detergent-free buffer or buffer containing 0.2% β -D-decylmaltopyranoside (depending on the downstream application). The VgrG1-Tse6-EagT6 2 -EF-Tu-Tsi6 complexes were then further purified by Ni-NTA chromatography and size exclusion chromatography as described previously 19 . For the detergent-bound complex, a second purification step using a Superose 6 Increase 5/150 column was performed.
Reconstitution into nanodiscs. The VgrG1-Tse6-EF-Tu-Tsi6 solubilized in detergent (β -D-decylmaltopyranoside) was mixed with preformed nanodiscs (Cube Biotech), containing MSP1D1-Δ H5 and 1-palmitoyl-2-oleoyl-glycero-3-phosphocholine (POPC), at a molar ratio of 1:4 and dialysed against ND-buffer (20 mM Tris-HCl, pH 8.0; 300 mM NaCl) for 96 h at room temperature. The NDbuffer was exchanged with fresh buffer after 24 h. Subsequently, size-exclusion chromatography with a Superose 6 Increase 10/300 GL column (GE Healthcare) was used to separate aggregates and/or empty nanodiscs, as well as nonreconstituted complexes.
Co-purification and co-immunoprecipitation assays. Full-length Tse6 and its truncated variants Tse6 ΔTMD-1 , Tse6 ΔTMD-2 and Tse6 ΔTMD-1,ΔTMD-2 were cloned into MCS-1 of pETDuet-1 using the NcoI/HindIII restriction sites and a 3ʹ primer that fuses a His 8 -tag to the C terminus of the protein. To neutralize effector cytotoxicity during overexpression in E. coli, these Tse6 variants were cloned into pETDuet-1 already containing the tsi6 gene in MCS-2 as described previously 19 . The resulting plasmids contained C-terminal His 8 -tagged Tse6 variants and untagged Tsi6. To elucidate EagT6 binding sites on Tse6, the above pETDuet-1 plasmids were co-transformed with pPSV35-CV::eagT6 in E. coli BL21 (DE3) Codon Plus cells. Protein expression was performed using conditions similar to those used for the expression of the VgrG1-Tse6-EagT6 2 -EF-Tu-Tsi6 complex, except 100 ml culture volumes were used. Pelleted cells were resuspended in 4 ml 50 mM TrisHCl pH 8.0, 300 mM NaCl, 5 mM imidazole before lysis by sonication. Cleared lysates were purified using Ni-NTA agarose (Qiagen) as per the instructions of the manufacturer. The presence or absence of an interaction between EagT6 and the Tse6 variants was assessed through SDS-PAGE followed by TGX staining (BioRad). To assess VgrG1 binding, E. coli BL21 (DE3) cells were transformed with the pETDuet-1::vgrG1-FLAG plasmid. Overnight cultures in the stationary phase were sub-inoculated into 300 ml LB and protein expression was induced as described for the VgrG1-Tse6-EagT6 2 -EF-Tu-Tsi6 complex. Seventy-five millilitres culture were co-pelleted with 75 ml of each of the BL21 (DE3) CodonPlus strains co-expressing EagT6 with either Tse6 or the various Tse6 truncations. Following cell lysis by sonication, 50 μ l aliquots constituting the input fraction were mixed 1:1 with SDS-PAGE sample-loading buffer and boiled for 10 min. The remainder of the lysate was incubated with Ni-NTA agarose beads for 1.5 h, washed extensively with lysis buffer and eluted using lysis buffer supplemented with 400 mM imidazole. Elution samples were prepared similarly to the input fraction and all samples were analysed by SDS-PAGE and western blotting.
Tsi6 depletion assays.
A sequence encoding the C-terminal DAS + 4 degradation tag was fused to the 3ʹ end of the native tsi6 locus in P. aeruginosa strains lacking the native sspB gene and expressing either wild-type Tse6 or Tse6 ΔTMD-1,ΔTMD-2 . An IPTG-inducible plasmid containing sspB was used to stimulate controlled degradation of Tsi6-DAS + 4 (Tsi6-D4). The SspB protein recognizes DAS + 4 tagged proteins and delivers them to the ClpXP protease for degradation. Strains harbouring this plasmid were streaked on LB agar supplemented with 500 μ M IPTG.
Secretion assays. Overnight cultures of P. aeruginosa strains were used to inoculate 2 ml LB at a ratio of 1:500. Cultures were grown at 37 °C with shaking to mid-log phase, and cell and supernatant fractions were prepared as described previously 3 .
Western blotting. Western blot analyses of protein samples were performed as described previously 3 using rabbit anti-VSV-G (diluted 1:5,000; Sigma), mouse anti-FLAG (diluted 1:5,000; Sigma) rabbit anti-Tse1 (diluted 1:2,000), rabbit anti-Tse6 (diluted 1:3,000) or mouse anti-RNAP (diluted 1:5,000; Sigma) and detected with anti-rabbit or anti-mouse horseradish peroxidase-conjugated secondary antibodies (diluted 1:5,000; Sigma). Western blots were developed using chemiluminescent substrate (Clarity Max, Bio-Rad) and imaged with the ChemiDoc Imaging System (Bio-Rad).
Competition assays. Recipient P. aeruginosa strains contained lacZ insertion at the neutral phage attachment site (attB) to differentiate these from an unlabelled donor. Overnight cultures of donor and recipient strains were mixed in a 1:1 (v/v) ratio and diluted 1:2 (v/v) in LB. Starting ratios of donor and recipient were enumerated by plating on LB agar containing 40 μ g ml −1 X-gal. Five microlitres of each competition mixture was then spotted in triplicate on a 0.2 μ m nitrocellulose membrane overlaid on a 3% LB agar plate and incubated face up at 37 °C for 18-20 h. Competitions were then harvested by resuspending cells in LB and enumerating colony-forming units by plating on LB agar containing 40 μ g ml
X-gal. The final ratio of donor/recipient colony-forming units were normalized to the starting ratio of donor and recipient strains.
E. coli toxicity assays. Plasmids containing Tse6 ΔTMD-1,ΔTMD-2 were not tolerated under non-inducing conditions. Therefore, splicing by overlap extension PCR was used to generate a variant (D396A) that we previously demonstrated reduces, but does not abolish, the toxic NADase activity of Tse6 19 . To allow for the pairwise comparison of toxicity levels between strains, this amino acid substitution was also introduced into the plasmids expressing Tse6 and Tse6 tox (Supplementary Table 3 ). E. coli BL21 Codon Plus cells were co-transformed with either pSCrhaB2-CV or pSCrhaB2-CV expressing full-length Tse6, Tse6 tox or Tse6 ΔTMD-1,ΔTMD-2 and either pPSV35-CV or pPSV35-CV expressing EagT6. Overnight cultures of these cells were diluted 1:10 6 in 10-fold increments and each dilution was spotted onto LB agar plates containing 0.1% (w/v) L-rhamnose, 0.1 mM IPTG and the appropriate antibiotics. Photographs were taken after overnight growth at 37°C.
Negative-stain electron microscopy. Four microlitres of sample at a concentration of 0.01 mg ml −1 were applied onto glow-discharged carbon-coated copper grids. After 60 s of incubation at room temperature, excess liquid was blotted away with Whatman No. 4 filter paper. The grids were then subjected to two wash steps with purification buffer and subsequently stained with 0.75% (w/v) uranyl formate. Images were recorded manually with a JEOL JEM-1400 microscope, equipped with a LaB 6 cathode and 4k × 4k CMOS detector F416 (TVIPS), operating at 120 kV.
Sample vitrification. Three microlitres VgrG1-Tse6-EagT6 2 -EF-Tu-Tsi6 complex, at a concentration of 0.015 mg ml −1 , was applied onto freshly glow-discharged Quantifoil 2/1 (with 2 nm additional carbon layer) cryo-EM grids, automatically blotted and plunged into liquid ethane using a CryoPlunge3 (Gatan) at a humidity between 90 and 100%. For the Tse6-loaded VgrG1 complex in nanodiscs, 3 µ l of 0.02 mg ml −1 was applied onto freshly glow-discharged QF 2/1 (2 nm additional carbon) grids, and subsequently blotted and plunged using a Vitrobot (FEI) at 100% humidity. To improve ice quality and distribution, 0.01% Tween-20 was added during this step. Grid quality was assessed before data collection using a JEOL JEM-1400 (see above) or JEOL JEM-3200FSC equipped with a FEG and an in-column energy filter, operating at 300 kV. Grids were kept in liquid nitrogen for long-term storage.
Cryo-EM and image processing. Two cryo-EM datasets for the PFC complex were collected on a Titan Krios electron microscope (FEI) equipped with a C s -Corrector, operated at 300 kV acceleration. Micrographs were recorded on a Falcon II direct electron detector (FEI) at a × 122,807 magnification (× 59,000 nominal magnification), corresponding to a pixel size of 1.14 Å. Twenty-four frames taken at intervals of 62.5 ms were collected during each exposure, resulting in a total exposure time of 1.5 s and a total electron dose of 60 e -/Å 2 . Using the automated data collection software EPU (FEI), two datasets, with a defocus range of 1.7-4.2 µ m, were automatically collected featuring 5,822 and 5,820 micrographs, respectively. The 24 frames were aligned and summed with the help of MotionCor2 (3 × 3 patches) 33, 34 . Furthermore, dose-weighted and unweighted full-dose images were calculated. Data processing was performed using the software package SPHIRE/EMAN2 25 . Unweighted full-dose images were used for defocus and astigmatism determination with CTER (SPHIRE). After merging both datasets and visually inspecting the integrated images, 8,744 micrographs were selected for subsequent processing. A combination of manual and automated particle selection, as well as several rounds of 2D classification, yielded 137,906 'clean' dose-weighted and drift-corrected particles that were extracted with a final window size of 360 × 360 pixels ( Supplementary Fig. 2a,c) . Two-dimensional classification was performed using the iterative stable alignment and clustering (ISAC) algorithm implemented in SPHIRE. The particle stack was subjected to sxmeridien (3D refinement in SPHIRE) with imposed C 3 symmetry, resulting in a 3.6 Å map of the C 3 symmetric VgrG1 (top) part of the complex, estimated by the 'gold standard' criterion of Fourier shell correlation (FSC) = 0.143. The determined 3D projection parameters for each particle were subsequently used to create a symmetrized particle stack. This new stack contained three copies of each original particle with projection parameters rotated by 120° along the (C 3 -) symmetry axis. The ensuing 3D classification resulted in three volumes that were rotated 120° to each other ( Supplementary Fig. 4 ). As anticipated, the three copies of the original particle were evenly distributed to these classes. However, given that classification procedures are not perfect in reality, we further confirmed that no more than one copy of the original particle is present in each class. Finally, one of the classes, containing 55,000 particles, was selected and subjected to a new local 3D refinement without imposing symmetry. This resulted in the 4.2 Å density map of the PFC, where the resolution of the EM density decreases towards the periphery of the map (Supplementary Fig. 1b) . Global resolutions were calculated between two independently refined half maps at the 0.143 FSC criterion, local resolution was calculated using sxlocres of SPHIRE. Final densities were filtered to an estimated average resolution. To visualize local resolution gradients within the map, it was coloured according to the local resolution in Chimera 35 . Graphical rendering of 3D average and variability was calculated using 'sx3dvariability' of the SPHIRE software package and filtered for illustrative purposes. The final electron density map allowed for the placement of crystal structures of EagT6 (PDB:1TU1) and the homology model of the Tse6 PAAR domain (Phyre2 web server) 26 using the 'Rigid-body Fit-in-Map' tool of Chimera. Rosetta was used to perform a relaxation of the known crystal structure of VgrG1 (PDB:4MTK) into the obtained cryo-EM density map 36 . The cryo-EM dataset for the Tse6-loaded VgrG1 complex in nanodiscs was collected on the same Titan Krios microscope as described above, using a K2 direct electron detector (Gatan) with in-column energy filter and a × 80,893 magnification (× 59,000 nominal magnification), yielding a pixel size of 1.1 Å. In total 100 frames (each 150 ms) were recorded, resulting in a total exposure time of 15 s and a total electron dose of 91 e -/Å 2 . Micrographs (n = 1,873) were automatically collected using EPU software, with a defocus range of 0.5-3.2 µ m and an energy filter width of 15 eV. Frame alignment and summing was performed with MotionCor2 (3 × 3 patches) and unweighted full-dose, dose-weighted fulldose and low-dose images were generated (15 e -without first frame/25 e -without first frame). After visual inspection, 1,358 micrographs were selected for further processing and unweighted full-dose images were used for contrast transfer function estimation with CTER. Particles (n = 114,879) were manually selected using EMAN2 boxer and extracted from dose-weighted full-dose images with a final box size of 360 × 360 pixels. Two-dimensional classification ISAC and visual sorting yielded a total number of 72,190 particles that were subjected to 3D refinement with imposed C 3 symmetry ( Supplementary Fig. 2b,c) . The obtained final reconstruction had an average resolution of 3.33 Å. To further improve the resolution, the last iterations of the 3D refinement were performed in continuing mode with extracted particles of the 25 e -without 1 st frame-low-dose images, resulting in a 3.25 Å electron density map. Rosetta was subsequently used to perform a relaxation of the known crystal structure of VgrG1 (PDB:4MTK) into the cryo-EM density map. Local resolution was calculated and visualized as described above. The low-resolution map of the Tse6-loaded VgrG1 complex with an overall resolution of 10.7 Å was obtained by using only 2D classes where the nanodisc was almost perpendicular to VgrG1 (in total 11,000 particles, C1 refinement) ( Supplementary Fig. 2b,c) .
Angular distribution plots for all structures, as well as beautified 2D class averages, were calculated using SPHIRE (Supplementary Figs 2c,3) . Nanogold staining. To detect His-tagged proteins, samples were incubated for 1 h with a 5 nm Ni-NTA Nanogold solution (Nanoprobes) on ice at a 9:1 (v/v) ratio and subsequently negatively stained according to the procedure described above.
Fluorescence-based liposome assay. POPC liposomes encapsulating NAD
+ were prepared by sonication and freeze-thaw cycles. POPC (Avanti Polar lipids) was added to LS NAD -assay buffer (20 mM Tris-HCl, pH 8.0; 150 mM NaCl; 50 mM NAD + ) to obtain a final concentration of 10 mg ml −1
. After 30 min sonication, followed by four freeze-thaw cycles (− 196 and 40 ˚C, respectively), liposomes were separated from non-encapsulated NAD + via two rounds of PD midiTrap G-25 columns equilibrated with LS-assay buffer (20 mM Tris-HCl, pH 8.0; 150 mM NaCl) following the manufacturer's instructions (only the first 0.8 ml of a 1.5 ml total elution was used for subsequent steps to ensure the absence of nonencapsulated NAD + ). Liposome assays were performed in 96-well plate format. Twenty microlitres of liposomes containing 50 mM NAD + were mixed with 10 µ l sample and filled up to final volume of 100 µ l with LS-assay buffer. The samples were prepared as follows: Tse6 WT : 0.7 mg ml −1 Tse6-complex in LS-assay buffer containing 0.03% n-decyl-β -D-maltoside (DM; Anatrace); buffer DM (LS-assay buffer + 0.03% DM); Tse6 Q333A, D396A : 0.7 mg ml −1 catalytically inactive mutant complex in LS-assay buffer containing 0.03% DM; Tse6 Δtox : 0.7 mg ml −1 complex of Tse6 mutant lacking its C-terminal domain in LS-assay buffer containing 0.03% DM, BSA (0.5 mg ml −1 BSA in LS-assay buffer + 0.03% DM)). After 16 h of incubation at 37 ˚C with rotation (300 rpm), samples were heated for 15 min at 96 ˚C to stop the reaction and 15 µ l 7.66% (v/v) Triton X-100 (1% (v/v) final concentration) was added and incubated for 10 min to permeabilize liposomes and release NAD + . After the addition of 35 µ l 8.57 M NaOH (2 M final concentration) reactions were incubated for 30 min in the dark to allow for the development of the base-catalysed fluorescent breakdown product of NAD + . Subsequently, plates were analysed using a POLARstar Omega plate reader with the following optical settings: excitation wavelength of 355 nm and emission of 400-10 nm. All reactions were measured in triplicate.
Bioinformatic tools. Multiple sequence alignments were carried out with the Clustal Omega server (EMBL-EBI, https://www.ebi.ac.uk/Tools/msa/clustalo/). Sequence logos were generated using WebLogo3 server (https://weblogo.berkeley. edu/logo.cgi). Vizualization of sequence conservation was done with Jalview 37 . For prediction of membrane topology the TOPCONS server 38 , as well as the TopGraph server were used 39 . Visualization, analysis and figure preparation was done with Chimera (UCSF) 35 .
Statistics and reproducibility. Digital electron micrographs were recorded multiple times with similar results and representative areas are shown in the figures (Figs 4d,5c, Supplementary Figs 1a,e,2c,8 and 9 ). Two-dimensional class averages were generated using the ISAC algorithm implemented in SPHIRE 40 that is based on reproducible K-means classification. It determines validated and homogenous subsets of images by repeatedly testing the stability and reproducibility of the calculated solution (Figs 3a,5a,d,  Supplementary Figs 1a,e and 2c ). All gels, as well as western blots, were repeated at least twice with similar results (Figs. 1d,2b,4a The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement An indication of whether measurements were taken from distinct samples or whether the same sample was measured repeatedly
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Software and code
Policy information about availability of computer code Data collection EPU software from FEI was used to collect cryo-EM data.
Data analysis
Particle picking was performed using Sparx. 3D variability analysis and local resolution estimations were performed with SPHIRE 2017.06.02. MotionCor2, Chimera 1.10.1, Rosetta
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The cryo-EM density maps of the PFC and the VgrG1-Tse6-EF-Tu complex in nanodisc are deposited into the Electron Microscopy Data Bank with the accession
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numbers EMD-0135 and EMD-0136, respectively. The refined models of VgrG1 in the PFC and the VgrG1-Tse6-EF-Tu complex in nanodisc have the PDB entry ID of 6H3L and 6H3N, respectively. Relevant data and details of plasmids and strains are available from the corresponding author upon request.
Field-specific reporting All studies must disclose on these points even when the disclosure is negative.
Sample size
No statistical method was used. The total number of electron micrographs in a dataset depended on the number of particles per image. The aim was to obtain a sufficiently high number of particles to achive a high resolution reconstruction of the protein of interest.
Data exclusions Electron micrographs with high drift or severe ice contaminations were discarded and not used in the subsequent image processing.
Replication
Findings could be reliably reproduced. See also "statistics and reproducibility" section.
Randomization Images of random holes with similar ice conditions were collected during data aquisition.
Blinding
The investigator was not completely blinded during the experiment.
Reporting for specific materials, systems and methods Detektion via anti-rabbit or anti-mouse horseradish peroxidase-conjugated secondary antibodies (diluted 1:5000, Sigma). More detailed information are available upon request.
Validation
Tse6 was validated by western blot comparing a Pseudomonas aeruginosa strain expressing Tse6 to a P. aeruginosa strain lacking Tse6. Tse1 was validated by western blot comparing a Pseudomonas aeruginosa strain expressing Tse1 to a P. aeruginosa strain lacking Tse1.
